Medical Properties (MPT) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.01
- EPS estimate
- $0.00
- EPS surprise
- −312.77%
- Revenue surprise
- +4.86%
- Revenue
- $259.3M
- Revenue estimate
- $247.3M
- Reported
- Aug 10, 2026
Medical Properties Trust reported Q2 2026 results on August 10, 2026. It posted a loss of $0.01 per share, against a breakeven estimate, a surprise of −312.77%. Revenue was $259.3 million, 4.86% above the $247.3 million consensus. Compared with Q2 2025, the loss narrowed from $0.16 per share and revenue rose about 8% from $240.4 million.
The table shows a long stretch of losses after 2022. Annual EPS was a profit of $1.50 in 2022, then losses of $0.94 in 2023, $3.80 in 2024 and $0.46 in 2025. The deepest quarterly loss was $1.34 in Q3 2024. Revenue fell from $1.54 billion in 2022 to $995.5 million in 2024 and $972.0 million in 2025. Q4 2025 and Q1 2026 were small profits of $0.03 and $0.05, before the slight loss in Q2. Over the last 12 quarters, EPS beat the estimate only twice, while revenue topped its estimate in 14 of the 19 quarters with figures.
Third-quarter results were reported between October 26 and November 7 in each of the past five years. That points to late October or early November 2026 for the next report. It will show whether results return to a profit.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 10, 2026 | $0.00 | −$0.01 | −312.77% | $259.3M | SEC |
| Q1 2026 | Apr 30, 2026 | $0.03 | $0.05 | +81.82% | $252.1M | SEC |
| Q4 2025 | Feb 19, 2026 | $0.01 | $0.03 | +130.77% | $270.3M | SEC |
| Q3 2025 | Oct 30, 2025 | $0.01 | −$0.13 | −1201.69% | $237.5M | SEC |
| Q2 2025 | Jul 31, 2025 | −$0.00 | −$0.16 | −11328.57% | $240.4M | SEC |
| Q1 2025 | May 1, 2025 | $0.01 | −$0.20 | −1969.16% | $223.8M | SEC |
| Q4 2024 | Feb 27, 2025 | −$0.06 | −$0.69 | −1089.66% | $231.8M | SEC |
| Q3 2024 | Nov 7, 2024 | $0.02 | −$1.34 | −5614.40% | $225.8M | SEC |
| Q2 2024 | Aug 8, 2024 | $0.04 | −$0.54 | −1313.48% | $266.6M | SEC |
| Q1 2024 | May 9, 2024 | $0.09 | −$1.23 | −1468.19% | $271.3M | SEC |
| Q4 2023 | Feb 21, 2024 | $0.15 | −$1.11 | −860.80% | −$122.4M | SEC |
| Q3 2023 | Oct 26, 2023 | $0.19 | $0.19 | −0.78% | $306.6M | SEC |
| Q2 2023 | Aug 8, 2023 | $0.22 | −$0.07 | −132.15% | $337.4M | SEC |
| Q1 2023 | Apr 27, 2023 | $0.22 | $0.05 | −77.53% | $350.2M | SEC |
| Q4 2022 | Feb 23, 2023 | $0.27 | −$0.24 | −187.56% | $380.5M | SEC |
| Q3 2022 | Oct 27, 2022 | $0.30 | $0.37 | +22.76% | $352.3M | SEC |
| Q2 2022 | Aug 3, 2022 | $0.30 | $0.32 | +8.29% | $400.2M | SEC |
| Q1 2022 | Apr 28, 2022 | $0.31 | $1.05 | +243.70% | $409.8M | SEC |
| Q4 2021 | Feb 3, 2022 | $0.31 | $0.34 | +9.43% | $409.3M | SEC |
| Q3 2021 | Oct 28, 2021 | $0.28 | $0.29 | +2.91% | $390.8M | SEC |
Quarterly revenue
Frequently asked questions
When did Medical Properties (MPT) last report earnings?
Medical Properties last reported on Aug 10, 2026, covering fiscal Q2 2026.
Did MPT beat earnings estimates?
No. Medical Properties reported EPS of −$0.01 for Q2 2026 against a $0.00 estimate — a 312.77% miss.
How much revenue did MPT report last quarter?
Medical Properties reported $259.3M in revenue for Q2 2026, against a consensus estimate of $247.3M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.